State Street’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.56M Buy
470,270
+14,876
+3% +$112K ﹤0.01% 3081
2025
Q1
$2.51M Sell
455,394
-5,590
-1% -$30.9K ﹤0.01% 3164
2024
Q4
$2.65M Buy
460,984
+11,009
+2% +$63.3K ﹤0.01% 3225
2024
Q3
$4.66M Buy
449,975
+27,147
+6% +$281K ﹤0.01% 3003
2024
Q2
$5.48M Sell
422,828
-1,137
-0.3% -$14.7K ﹤0.01% 2889
2024
Q1
$7.4M Sell
423,965
-1,675
-0.4% -$29.2K ﹤0.01% 2747
2023
Q4
$4.01M Sell
425,640
-24,518
-5% -$231K ﹤0.01% 3046
2023
Q3
$5.03M Sell
450,158
-1,068,093
-70% -$11.9M ﹤0.01% 2915
2023
Q2
$32.5M Buy
1,518,251
+317,315
+26% +$6.79M ﹤0.01% 1926
2023
Q1
$48.6M Sell
1,200,936
-311,256
-21% -$12.6M ﹤0.01% 1669
2022
Q4
$70.3M Buy
1,512,192
+134,775
+10% +$6.27M ﹤0.01% 1408
2022
Q3
$71.4M Sell
1,377,417
-322,011
-19% -$16.7M ﹤0.01% 1341
2022
Q2
$80.3M Buy
1,699,428
+390,842
+30% +$18.5M ﹤0.01% 1323
2022
Q1
$93.1M Buy
1,308,586
+181,517
+16% +$12.9M ﹤0.01% 1341
2021
Q4
$84.3M Buy
1,127,069
+54,887
+5% +$4.1M ﹤0.01% 1436
2021
Q3
$60.9M Buy
1,072,182
+18,107
+2% +$1.03M ﹤0.01% 1659
2021
Q2
$46.4M Sell
1,054,075
-44,049
-4% -$1.94M ﹤0.01% 1903
2021
Q1
$54.2M Sell
1,098,124
-75,116
-6% -$3.7M ﹤0.01% 1688
2020
Q4
$49.4M Buy
1,173,240
+209,722
+22% +$8.83M ﹤0.01% 1649
2020
Q3
$44.1M Sell
963,518
-95,578
-9% -$4.38M ﹤0.01% 1550
2020
Q2
$53.2M Buy
1,059,096
+151,172
+17% +$7.59M ﹤0.01% 1428
2020
Q1
$46.7M Buy
907,924
+77,071
+9% +$3.96M ﹤0.01% 1301
2019
Q4
$51.3M Sell
830,853
-52,183
-6% -$3.22M ﹤0.01% 1505
2019
Q3
$53.1M Buy
883,036
+22,678
+3% +$1.36M ﹤0.01% 1403
2019
Q2
$72.6M Sell
860,358
-60,095
-7% -$5.07M 0.01% 1243
2019
Q1
$87.9M Sell
920,453
-40,626
-4% -$3.88M 0.01% 1089
2018
Q4
$68.1M Sell
961,079
-238,088
-20% -$16.9M 0.01% 1154
2018
Q3
$102M Buy
1,199,167
+428,868
+56% +$36.7M 0.01% 1062
2018
Q2
$89.3M Buy
770,299
+12,500
+2% +$1.45M 0.01% 1117
2018
Q1
$61.3M Buy
757,799
+35,903
+5% +$2.9M 0.01% 1297
2017
Q4
$42.4M Buy
721,896
+897
+0.1% +$52.6K ﹤0.01% 1529
2017
Q3
$33.7M Buy
720,999
+34,952
+5% +$1.64M ﹤0.01% 1643
2017
Q2
$24.7M Sell
686,047
-62,777
-8% -$2.26M ﹤0.01% 1839
2017
Q1
$23.1M Buy
748,824
+180,586
+32% +$5.56M ﹤0.01% 1830
2016
Q4
$19M Buy
568,238
+236,871
+71% +$7.94M ﹤0.01% 1935
2016
Q3
$8.82M Sell
331,367
-320,894
-49% -$8.54M ﹤0.01% 2253
2016
Q2
$14.4M Buy
652,261
+70,709
+12% +$1.56M ﹤0.01% 1986
2016
Q1
$17.1M Sell
581,552
-3,008
-0.5% -$88.3K ﹤0.01% 1832
2015
Q4
$19.3M Sell
584,560
-311,053
-35% -$10.3M ﹤0.01% 1737
2015
Q3
$32.4M Buy
895,613
+52,503
+6% +$1.9M ﹤0.01% 1420
2015
Q2
$37.9M Buy
843,110
+64,582
+8% +$2.91M ﹤0.01% 1430
2015
Q1
$23.8M Buy
778,528
+256,754
+49% +$7.86M ﹤0.01% 1733
2014
Q4
$26.5M Buy
521,774
+397,077
+318% +$20.2M ﹤0.01% 1598
2014
Q3
$4.94M Buy
124,697
+1,900
+2% +$75.2K ﹤0.01% 2556
2014
Q2
$5.29M Buy
122,797
+72,153
+142% +$3.11M ﹤0.01% 2564
2014
Q1
$2.03M Buy
50,644
+7,844
+18% +$314K ﹤0.01% 3059
2013
Q4
$1.17M Buy
42,800
+8,603
+25% +$235K ﹤0.01% 3227
2013
Q3
$783K Buy
+34,197
New +$783K ﹤0.01% 3289